`
`BEFORE THE PA TENT TRIAL AND APPEAL BOARD
`
`Taro Pharmaceuticals U.S.A., Inc.,
`
`v.
`
`Apotex Technologies, Inc.
`
`Patent No. 7,049,328 B2
`
`Title: USE FOR DEFERIPRONE
`
`POWER OF ATTORNEY
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`Pursuant to 37 C.F.R. 42.1 O(b ), Petitioner Taro Pharmaceuticals USA, Inc.
`
`hereby appoints the following practitioners associated with Goodwin Procter LLP
`
`as its attorneys to transact all business in the United States Patent and Trademark
`
`Office associated with the above-captioned inter partes review of U.S. Patent No.
`
`7,049,328:
`
`Hui ya Wu (lead counsel, Reg. No. 44,411)
`Robert V. Cerwinski (backup counsel, to seek pro hac vice admission)
`Sarah Fink (backup counsel, Reg. No. 64,886)
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth A venue
`New York, NY 10018-1405
`Tel: (212) 813-8800
`Fax: (212) 355-3333
`HWu@goodwinlaw.com
`RCerwinski@goodwinlaw.com
`SFink@goodwinlaw.com
`
`The undersigned is empowered to act on behalf of Petitioner Taro Pharmaceuticals
`
`USA, Inc.
`
`By:
`
`Name:
`
`Title:
`
`Date:
`
`Craig Kuchii
`
`Senior Director - Intellectual
`Property
`
`May 15, 2017
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. §§ 42.6(e) and 42.105, I certify that on May 16, 2017,
`
`I served a copy of this TARO PHARMACEUTICAL USA, INC.’S POWER OF
`
`ATTORNEY by Federal Express Next Business Day Delivery on the following
`
`addresses for patent owner(s) and their representatives:
`
`Apotex Technologies, Inc.
`150 Signet Drive
`Toronto, Canada M9L IT9
`
`Carl Scott
`333 Bay Street, Suite 3400
`Toronto, M5H, 2S7 Canada
`
`
`
`
`
`
`
`/Russell W. Warnick/
`Russell W. Warnick
`GOODWIN PROCTER LLP
`901 New York Avenue
`Washington, DC 20001
`
`
`
`